Entry |
|
Name |
Aminocaproic acid (USP/INN); Epsilon-Aminocaproic acid (JAN); Amicar (TN) |
Product |
|
Generic |
AMINOCAPROIC ACID (ANI Pharmaceuticals), AMINOCAPROIC ACID (Akorn Operating Company LLC), AMINOCAPROIC ACID (American Health Packaging), AMINOCAPROIC ACID (American Regent), AMINOCAPROIC ACID (American Regent), AMINOCAPROIC ACID (Amneal Pharmaceuticals NY LLC), AMINOCAPROIC ACID (Amneal Pharmaceuticals NY LLC), AMINOCAPROIC ACID (Aurobindo Pharma Limited), AMINOCAPROIC ACID (BPI LABS LLC), AMINOCAPROIC ACID (Biocon Pharma), AMINOCAPROIC ACID (Biocon Pharma), AMINOCAPROIC ACID (Camber Pharmaceuticals), AMINOCAPROIC ACID (Carnegie Pharmaceuticals), AMINOCAPROIC ACID (Carnegie Pharmaceuticals), AMINOCAPROIC ACID (Civica), AMINOCAPROIC ACID (Edenbridge Pharmaceuticals LLC.), AMINOCAPROIC ACID (Henry Schein), AMINOCAPROIC ACID (Hospira), AMINOCAPROIC ACID (Major Pharmaceuticals), AMINOCAPROIC ACID (Medical Purchasing Solutions), AMINOCAPROIC ACID (Novadoz Pharmaceuticals LLC), AMINOCAPROIC ACID (PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS), AMINOCAPROIC ACID (Taro Pharmaceuticals U.S.A.), AMINOCAPROIC ACID (TruPharma LLC), AMINOCAPROIC ACID (Vitruvias Therapeutics), AMINOCAPROIC ACID (Vitruvias Therapeutics) |
Formula |
C6H13NO2
|
Exact mass |
131.0946
|
Mol weight |
131.17
|
Structure |
|
Simcomp |
|
Class |
|
Remark |
|
Efficacy |
Antifibrinolytic, Anti-inflammatory, Plasmin inhibitor |
Target |
|
Pathway |
hsa04610 | Complement and coagulation cascades |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02A ANTIFIBRINOLYTICS
B02AA Amino acids
B02AA01 Aminocaproic acid
D00160 Aminocaproic acid (USP/INN) <US>
USP drug classification [BR:br08302]
Blood Products and Modifiers
Hemostasis Agents
Aminocaproic Acid
D00160 Aminocaproic acid (USP/INN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for ophthalmologic use
62 General eye drops
D00160 Aminocaproic acid (USP/INN)
67 Eyewash
D00160 Aminocaproic acid (USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
Epsilon-Aminocaproic acid
D00160 Aminocaproic acid (USP/INN)
Drug groups [BR:br08330]
Blood modifier agent
DG02016 Hemostatics
DG02012 Antifibrinolytic
DG01540 Plasmin inhibitor
D00160 Aminocaproic acid
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Serine peptidases
PLG
D00160 Aminocaproic acid (USP/INN) <US>
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 9
1 C1b C 21.8300 -17.6973
2 C1b C 23.0454 -18.3901
3 C1b C 20.6147 -18.3960
4 C6a C 24.2549 -17.6855
5 C1b C 19.4054 -17.7032
6 O6a O 25.4702 -18.3843
7 O6a O 24.2549 -16.2824
8 C1b C 18.1900 -18.4018
9 N1a N 16.9747 -17.7090
BOND 8
1 1 2 1
2 1 3 1
3 2 4 1
4 3 5 1
5 4 6 1
6 4 7 2
7 5 8 1
8 8 9 1
|